Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e1c56b88229114d57f1a0050eb922f6 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
filingDate |
2002-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bee357afd1380ff4a869ba66fbb787e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48109cf1f084a6f7827bfddb5f0b2ef6 |
publicationDate |
2004-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
NZ-521657-A |
titleOfInvention |
Free-flowing simethicone compositon for forming a solid oral dosage form |
abstract |
A composition for forming a compressed solid dosage form comprising a free-flowing compressible admixture of simethicone and an adsorbent, wherein the weight ratio of simethicone to adsorbent is at least about 1:2.00. The composition may also include an active ingredient such as bisacodyl, famotidine, diphenoylate, loperamide and mesalamine. |
priorityDate |
2001-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |